AnaptysBio Stock (NASDAQ: ANAB) stock price, news, charts, stock research, profile.
Open | $35.35 |
Close | $36.96 |
Volume / Avg. | 229.05K / 355.21K |
Day Range | 34.90 - 37.29 |
52 Wk Range | 13.36 - 37.28 |
Market Cap | $1.01B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 84 |
Short Interest | 25.33% |
Days to Cover | 12.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AnaptysBio (NASDAQ:ANAB) through any online brokerage.
Other companies in AnaptysBio’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB) and 4D Molecular Therapeutics (NASDAQ:FDMT).
There is no analysis for AnaptysBio.
AnaptysBio has a consensus price target of $47.07.
The stock price for AnaptysBio (NASDAQ: ANAB) is $36.96 last updated July 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for AnaptysBio.
AnaptysBio’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for AnaptysBio.
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.